Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1984 Jan;49(1):87–92. doi: 10.1038/bjc.1984.13

Multiple primary breast and thyroid cancer.

E Ron, R Curtis, D A Hoffman, J T Flannery
PMCID: PMC1976676  PMID: 6691901

Abstract

The occurrence of breast and thyroid multiple primary cancers was evaluated using data from the Connecticut Tumor Registry. The study population consisted of 1618 women with primary thyroid cancer and 39,194 women with primary breast cancer diagnosed between 1935 and 1978. Thirty-four thyroid cancer patients subsequently developed breast cancer and 24 breast cancer patients later had thyroid cancer. A significantly elevated risk of thyroid cancer following breast cancer (SIR = 1.68) and breast cancer following thyroid cancer (SIR = 1.89) was demonstrated. The finding was even more notable when compared with the risks obtained for other sites. The elevated risk was particularly evident in women under 40 years of age at time of diagnosis of the first cancer. Analysis by histologic type revealed that the highest risk of second primary breast cancer was found among patients with follicular or mixed papillary-follicular thyroid cancer. Women under age 40 with follicular carcinoma had a 10-fold risk of developing breast cancer (4 observed, 0.4 expected). An enhanced risk of second primary tumours was evident for the entire period after treatment of the first primary, although it was highest within one year after diagnosis of the first primary. This may be due to the close medical surveillance of cancer patients which would increase early diagnosis of second tumours. Our findings suggest that breast and thyroid cancer may share common aetiologic features.

Full text

PDF
87

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adami H. O., Rimsten A., Thorén L., Vegelius J., Wide L. Thyroid disease and function in breast cancer patients and non-hospitalized controls evaluated by determination of TSH, T3, rT3 and T4 levels in serum. Acta Chir Scand. 1978;144(2):89–97. [PubMed] [Google Scholar]
  2. Breslow N. E., Enstrom J. E. Geographic correlations between cancer mortality rates and alcohol-tobacco consumption in the United States. J Natl Cancer Inst. 1974 Sep;53(3):631–639. doi: 10.1093/jnci/53.3.631. [DOI] [PubMed] [Google Scholar]
  3. Chalstrey L. J., Benjamin B. High incidence of breast cancer in thyroid cancer patients. Br J Cancer. 1966 Dec;20(4):670–675. doi: 10.1038/bjc.1966.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cowan L. D., Gordis L., Tonascia J. A., Jones G. S. Breast cancer incidence in women with a history of progesterone deficiency. Am J Epidemiol. 1981 Aug;114(2):209–217. doi: 10.1093/oxfordjournals.aje.a113184. [DOI] [PubMed] [Google Scholar]
  5. Eskin B. A. Iodine metabolism and breast cancer. Trans N Y Acad Sci. 1970 Dec;32(8):911–947. doi: 10.1111/j.2164-0947.1970.tb02988.x. [DOI] [PubMed] [Google Scholar]
  6. HUMPHREY L. J., SWERDLOW M. THE RELATIONSHIP OF BREAST DISEASE TO THYROID DISEASE. Cancer. 1964 Sep;17:1170–1173. doi: 10.1002/1097-0142(196409)17:9<1170::aid-cncr2820170912>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  7. Hedley A. J., Jones S. J., Spiegelhalter D. J., Clements P., Bewsher P. D., Simpson J. G., Weir R. D. Breast cancer in thyroid disease: fact or fallacy? Lancet. 1981 Jan 17;1(8212):131–133. doi: 10.1016/s0140-6736(81)90712-1. [DOI] [PubMed] [Google Scholar]
  8. Heitz P., Moser H., Staub J. J. Thyroid cancer: a study of 573 thyroid tumors and 161 autopsy cases observed over a thirty-year period. Cancer. 1976 May;37(5):2329–2337. doi: 10.1002/1097-0142(197605)37:5<2329::aid-cncr2820370523>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  9. Hoffman D. A., McConahey W. M. Thyroid disease and breast cancer. Lancet. 1981 Mar 28;1(8222):730–730. doi: 10.1016/s0140-6736(81)92012-2. [DOI] [PubMed] [Google Scholar]
  10. Kapdi C. C., Wolfe J. N. Breast cancer. Relationship to thyroid supplements for hypothyroidism. JAMA. 1976 Sep 6;236(10):1124–1127. doi: 10.1001/jama.236.10.1124. [DOI] [PubMed] [Google Scholar]
  11. MacFarlane I. A., Robinson E. L., Bush H., Durning P., Howat J. M., Beardwell C. G., Shalet S. M. Thyroid function in patients with benign and malignant breast disease. Br J Cancer. 1980 Mar;41(3):478–480. doi: 10.1038/bjc.1980.73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mittra I., Hayward J. L. Hypothalamic-pituitary-thyroid axis in breast cancer. Lancet. 1974 May 11;1(7863):885–889. doi: 10.1016/s0140-6736(74)90344-4. [DOI] [PubMed] [Google Scholar]
  13. Monson R. R. Analysis of relative survival and proportional mortality. Comput Biomed Res. 1974 Aug;7(4):325–332. doi: 10.1016/0010-4809(74)90010-x. [DOI] [PubMed] [Google Scholar]
  14. Pochin E. E. Letter: Alcohol and cancer of breast and thyroid. Lancet. 1976 May 22;1(7969):1137–1137. doi: 10.1016/s0140-6736(76)99041-3. [DOI] [PubMed] [Google Scholar]
  15. REPERT R. W. Breast carcinoma study: relation to thyroid disease and diabetes. J Mich State Med Soc. 1952 Oct;51(10):1315–passim. [PubMed] [Google Scholar]
  16. Rose D. P., Davis T. E. Plasma thyroid-stimulating hormone and thyroxine concentrations in breast cancer. Cancer. 1978 Feb;41(2):666–669. doi: 10.1002/1097-0142(197802)41:2<666::aid-cncr2820410234>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  17. Schottenfeld D., Berg J. Incidence of miltiple primary cancers. IV. Cancers of the female breast and genital organs. J Natl Cancer Inst. 1971 Jan;46(1):161–170. [PubMed] [Google Scholar]
  18. Shands W. C., Gatling R. R. Cancer of the thyroid: review of 109 cases. Ann Surg. 1970 May;171(5):735–745. doi: 10.1097/00000658-197005000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Shapiro S., Slone D., Kaufman D. W., Rosenberg L., Miettinen O. S., Stolley P. D., Knapp R. C., Leavitt T., Jr, Watring W. G., Rosenshein N. B. Use of thyroid supplements in relation to the risk of breast cancer. JAMA. 1980 Oct 10;244(15):1685–1687. [PubMed] [Google Scholar]
  20. Stadel B. V. Dietary iodine and risk of breast, endometrial, and ovarian cancer. Lancet. 1976 Apr 24;1(7965):890–891. doi: 10.1016/s0140-6736(76)92102-4. [DOI] [PubMed] [Google Scholar]
  21. Williams R. R. Breast and thyroid cancer and malignant melanoma promoted by alcohol-induced pituitary secretion of prolactin, T.S.H. and M.S.H. Lancet. 1976 May 8;1(7967):996–999. doi: 10.1016/s0140-6736(76)91865-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES